TCL Archive Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant By Cancer History Project August 3, 2001
TCL Archive AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them By Cancer History Project May 16, 1975
TCL Archive FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza By Cancer History Project December 26, 2014
TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study By Cancer History Project December 26, 2014
TCL Archive Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk By Cancer History Project December 26, 2014
TCL Archive Imbruvica Improves PFS, OS In Phase III CLL Study By Cancer History Project December 26, 2014
TCL Archive Blincyto Demonstrates Response In Minimal Residual Disease ALL By Cancer History Project December 26, 2014
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
